Identification of Ginkgo biloba flavonol metabolites after oral administration to humans
An extract of Ginkgo biloba leaves (EGb) was given to healthy volunteers. Urine samples were collected for 3 days, and blood samples were withdrawn every 30 min for 5 h. The samples were purified through SPE C 18 cartridges and analyzed by reversed-phase LC–diode array detection for the presence of...
Saved in:
Published in | Journal of chromatography. Biomedical applications Vol. 693; no. 1; pp. 249 - 255 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
23.05.1997
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An extract of
Ginkgo biloba leaves (EGb) was given to healthy volunteers. Urine samples were collected for 3 days, and blood samples were withdrawn every 30 min for 5 h. The samples were purified through SPE C
18 cartridges and analyzed by reversed-phase LC–diode array detection for the presence of EGb metabolites. Only urine samples contained detectable amounts of substituted benzoic acids, i.e., 4-hydroxybenzoic acid conjugate, 4-hydroxyhippuric acid, 3-methoxy-4-hydroxyhippuric acid, 3,4-dihydroxybenzoic acid, 4-hydroxybenzoic acid, hippuric acid and 3-methoxy-4-hydroxybenzoic acid (vanillic acid). In contrast to rats no phenylacetic acid or phenylpropionic acid derivatives were found in urine, thus indicating that in humans a more extensive metabolism takes place. As for rats the metabolites found in human urines accounted for less than 30% of the flavonoids given. The same procedure was applied to blood samples, and no metabolites could be detected. |
---|---|
ISSN: | 0378-4347 |
DOI: | 10.1016/S0378-4347(96)00513-0 |